Korro Bio (KRRO) Non-Current Debt (2018 - 2022)
Korro Bio (KRRO) posted Non-Current Debt of $4.2 million for Q4 2022, down 37.5% on a QoQ basis from $6.7 million in Q3 2022, and down 70.59% year-over-year from $14.2 million in Q4 2021.
Korro Bio (KRRO) Non-Current Debt (2018 - 2022) Analysis & Trends
Korro Bio's Non-Current Debt history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2022.
- Quarterly Non-Current Debt fell 70.59% year-over-year to $4.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $4.2 million (down 70.59% YoY) and the FY2022 annual result came in at $4.2 million, down 70.59% from the prior year.
- Non-Current Debt was $4.2 million for Q4 2022 at Korro Bio, down from $6.7 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $15.0 million in Q4 2020 and bottomed at $180000.0 in Q4 2019.
- A 5-year average of $8.9 million and a median of $10.4 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2020 — Non-Current Debt jumped 8233.33% — and 2022, when it sank 70.59%.
- Korro Bio's Non-Current Debt stood at $349000.0 in 2018, then tumbled by 48.42% to $180000.0 in 2019, then soared by 8233.33% to $15.0 million in 2020, then slipped by 5.55% to $14.2 million in 2021, then plunged by 70.59% to $4.2 million in 2022.
- Business Quant data shows KRRO's Non-Current Debt at $4.2 million in Q4 2022, $6.7 million in Q3 2022, and $9.2 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 105.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 842.92 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 6.67 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | 11.67 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Mar 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 222,000.00 |
| Dec 31, 2018 | 349,000.00 |